Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bombardier

Showing results (111-120 of 180) with videos related to

Pageof 18
Sort By:
Clinical Rheumatology|August 7, 2015
The influence of age at disease onset on disease activity and disability: results from the Ontario Best Practices Research InitiativeT N Ruban, B Jacob, J E Pope, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 30, 1998
Preventing disability from work-related low-back pain. New evidence gives new hope--if we can just get all the players onsideJ Frank, S Sinclair, S Hogg-Johnson, et al.
Medical Care|April 1, 1995
Comparison of a generic and a disease-specific measure of pain and physical function after knee replacement surgeryC Bombardier, C A Melfi, J Paul, et al.
Arthritis and Rheumatism|October 1, 1991
Kidney biopsy in systemic lupus erythematosus. II. Survival analyses according to biopsy resultsJ McLaughlin, D D Gladman, M B Urowitz, et al.
Joint Bone Spine|October 12, 2004
Assessing damage in individual joints in rheumatoid arthritis: a new method based on the Larsen systemP Zangger, J R Kachura, C Bombardier, et al.
Arthritis and Rheumatism|October 8, 1999
Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators GroupV Strand, P Tugwell, C Bombardier, et al.
The Journal of Rheumatology|January 26, 1999
Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome Measures in RheumatologyM Gazarian, P Tugwell, M Boers, et al.
The Cochrane Database of Systematic Reviews|May 5, 2000
Injectable gold for rheumatoid arthritisP Clark, P Tugwell, K Bennet, et al.
Arthritis and Rheumatism|March 23, 2000
Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators GroupP Tugwell, G Wells, V Strand, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 17, 2007
Influence of factor IX on overall plasma coagulability and fibrinolytic potential as measured by global assay: monitoring in haemophilia BN A Goldenberg, C Bombardier, W E Hathaway, et al.
Pageof 18

Showing results (111-120 of 180) with videos related to

Sort By:
Pageof 18
Clinical Rheumatology|August 7, 2015
The influence of age at disease onset on disease activity and disability: results from the Ontario Best Practices Research InitiativeT N Ruban, B Jacob, J E Pope, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 30, 1998
Preventing disability from work-related low-back pain. New evidence gives new hope--if we can just get all the players onsideJ Frank, S Sinclair, S Hogg-Johnson, et al.
Medical Care|April 1, 1995
Comparison of a generic and a disease-specific measure of pain and physical function after knee replacement surgeryC Bombardier, C A Melfi, J Paul, et al.
Arthritis and Rheumatism|October 1, 1991
Kidney biopsy in systemic lupus erythematosus. II. Survival analyses according to biopsy resultsJ McLaughlin, D D Gladman, M B Urowitz, et al.
Joint Bone Spine|October 12, 2004
Assessing damage in individual joints in rheumatoid arthritis: a new method based on the Larsen systemP Zangger, J R Kachura, C Bombardier, et al.
Arthritis and Rheumatism|October 8, 1999
Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators GroupV Strand, P Tugwell, C Bombardier, et al.
The Journal of Rheumatology|January 26, 1999
Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome Measures in RheumatologyM Gazarian, P Tugwell, M Boers, et al.
The Cochrane Database of Systematic Reviews|May 5, 2000
Injectable gold for rheumatoid arthritisP Clark, P Tugwell, K Bennet, et al.
Arthritis and Rheumatism|March 23, 2000
Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators GroupP Tugwell, G Wells, V Strand, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 17, 2007
Influence of factor IX on overall plasma coagulability and fibrinolytic potential as measured by global assay: monitoring in haemophilia BN A Goldenberg, C Bombardier, W E Hathaway, et al.
Pageof 18